AMZN
Amazon.com, Inc.
AMZN has the edge over DHI overall, supported by stronger modeled upside and stronger valuation.
DHI
D.R. Horton, Inc.
DHI trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
DHI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
DHI's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over DHI in the historical PE scenario, which offers more potential upside but is not a forecast.
DHI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $68.46 | -53% |
| Fair | 10x | $105 | -28% |
| Expensive | 13x | $132 | -8.8% |
| Current | 14x | $144 | — |
| Forward | 17x | $144 | — |
Historical ranges are pointers, not guarantees.
DHI's PE is 14x, but its earnings don't support one, so it isn't a reliable read right now.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
AMZN has the edge over DHI on the outlook, with more favorable earnings and revenue expectations.
DHI Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Decline | |
| Stable | |
| Weakening | |
| Moderate | |
| Low |
Analysts expect DHI's earnings and profitability to decline, with its revenue holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over DHI in the latest year-over-year earnings comparison.
DHI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.71 | -14% |
| Q3 2026 | $10.14 | -12% |
DHI earned $10.14 per share over the past year, down 12% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over DHI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over DHI on profitability, with a higher operating margin.
DHI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.4B | -3.2% |
| Q2 2026 | $9.2B | 0% |
| Q1 2026 | $7.6B | -2.3% |
| Q4 2025 | $6.9B | -9.5% |
DHI's revenue has held roughly level: $9.4B last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 13% | -1.4 points |
| Q1 2026 | 11% | -2.3 points |
| Q4 2025 | 12% | -3 points |
| Q3 2025 | 12% | N/A |
| Q2 2025 | 15% | N/A |
| Q1 2025 | 14% | N/A |
| Q4 2024 | 15% | N/A |
DHI's operating margin was 13% last quarter, down 1.4 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
DHI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $397.3M | -43% |
| Q1 2026 | -$449.7M | +$20.8M |
| Q4 2025 | $826.6M | +31% |
DHI has the edge over AMZN in the latest year-over-year cash flow comparison.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
DHI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -6M shares |
| 1 year | -7.2% | -21.9M shares |
DHI has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $600M |
| Q1 2026 | $930.3M |
| Q4 2025 | $669.7M |
| Q3 2025 | $700M |
| Q2 2025 | $1B |
| Q1 2025 | $1.3B |
| Q4 2024 | $1.1B |
DHI spent $2.9B buying back its own shares over the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
DHI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
DHI has the edge over AMZN on leverage, with a lower net debt burden relative to earnings.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
DHI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.0 | Neutral |
| Stochastic | 60.0 | Neutral |
DHI's weekly RSI is 49 (neutral) and its Stochastic is 60 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
DHI PE vs Consumer Cyclical Sector
| Metric | DHI | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 21% below |
| PE % | 96 | 47 | 49 pts above |
DHI has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over DHI on trend strength, trading above more of its moving averages.
DHI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $142.6 | 1.3% above |
| 20 week MA | $145.2 | 0.5% below |
| 50 week MA | $148.3 | 2.6% below |
| 100 week MA | $144.7 | 0.2% below |
| 200 week MA | $140.9 | 2.5% above |
DHI's trend is mixed: it's above two of its five weekly moving averages, and 2.5% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over DHI on returns for 2026, with the stronger performance.
DHI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $52.9 | $71.9 | +36% |
| 2021 | $71.9 | $104.9 | +46% |
| 2022 | $104.9 | $89.2 | -15% |
| 2023 | $89.2 | $152.0 | +70% |
| 2024 | $152.0 | $140.3 | -7.7% |
| 2025 | $140.3 | $146.3 | +4.3% |
| 2026 YTD | $146.3 | $144.5 | -1.3% |
DHI has finished higher in four of the last six years. It's down 1.3% so far in 2026.